is tirzepatide on the market (Mounjaro): Novel Solution For Management Of Type 2 Diabetes And Obesity New Tirzepatide Access and Pricing

Key Takeaways Starting dose: 2mg once weekly for the first 4 weeks to assess tolerance Titration schedule: Increase every 4 weeks: 2mg 4mg 8mg 12mg (max) Half-life: Approximately 6 days, reaching steady state in 4-5 weeks Injection frequency: Once weekly on the same day each week Microdosing option: Some users split doses for improved tolerability Investigational Drug: Retatrutide is NOT FDA-approved and is currently only available through clinical trials

This does not reduce the total cost but can make the monthly cash flow more manageable

This promotes an idea that theres one look to health, but bodies come in a lot of different sizes, and healthy does not have a look, Cassetty says

Physiol Behav (2022) 257:113967